Cosenza, M., Civallero, M., Marcheselli, L., Sacchi, S., & Pozzi, S. (2020). Citarinostat and Momelotinib co-target HDAC6 and JAK2/STAT3 in lymphoid malignant cell lines: A potential new therapeutic combination. Apoptosis.
Citação norma ChicagoCosenza, Maria, Monica Civallero, Luigi Marcheselli, Stefano Sacchi, and Samantha Pozzi. "Citarinostat and Momelotinib Co-target HDAC6 and JAK2/STAT3 in Lymphoid Malignant Cell Lines: A Potential New Therapeutic Combination." Apoptosis 2020.
MLA CitationCosenza, Maria, et al. "Citarinostat and Momelotinib Co-target HDAC6 and JAK2/STAT3 in Lymphoid Malignant Cell Lines: A Potential New Therapeutic Combination." Apoptosis 2020.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.